“Bimekizumab Impact on Patient-Reported Outcomes in Patients With Moderate to Severe Hidradenitis Suppurativa: Pooled Week 48 Results from BE HEARD I&II”. SKIN The Journal of Cutaneous Medicine 8, no. 6 (November 18, 2024): s476. Accessed May 19, 2025. https://skin.dermsquared.com/skin/article/view/3078.